{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:38:50Z","timestamp":1784590730120,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11910-018-0843-5","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T02:42:58Z","timestamp":1527043378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Beh\u00e7et\u2019s Syndrome and Nervous System Involvement"],"prefix":"10.1007","volume":"18","author":[{"given":"U\u011fur","family":"Uyguno\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksel","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"843_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11926-003-0066-9","volume":"5","author":"H Yaz\u0131c\u0131","year":"2003","unstructured":"Yaz\u0131c\u0131 H. Beh\u00e7et syndrome: an update. Curr Rheumatol Rep. 2003;5:195\u2013219.","journal-title":"Curr Rheumatol Rep"},{"key":"843_CR2","doi-asserted-by":"crossref","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 1990; 335, 1078\u20131080.","DOI":"10.1016\/0140-6736(90)92643-V"},{"issue":"2","key":"843_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"\u2022\u2022 Yazici H, Seyahi E, Hatemi G, Yazici Y. Beh\u00e7et syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107\u201319. This comprehensive review discuss the concept of Beh\u00e7et syndrome together with the clinical, laboratory features and treatment options.","journal-title":"Nat Rev Rheumatol"},{"key":"843_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yaz\u0131c\u0131","year":"2007","unstructured":"Yaz\u0131c\u0131 H, Fresko I, Yurdakul S. Beh\u00e7et\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3:151\u20135.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"843_CR5","first-page":"820","volume":"15","author":"S Yurdakul","year":"1988","unstructured":"Yurdakul S, Gunaydin I, Tuzun Y, et al. The prevalence of Behcet\u2019s syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15(5):820\u20132.","journal-title":"J Rheumatol"},{"issue":"10","key":"843_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"G Azizlerli","year":"2003","unstructured":"Azizlerli G, K\u00f6se AA, Sarica R, G\u00fcl A, Tutkun IT, Kula\u00e7 M, et al. Prevalence of Behcet\u2019s disease in Istanbul, Turkey. Int J Dermatol. 2003;42(10):803\u20136.","journal-title":"Int J Dermatol"},{"key":"843_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","volume":"38","author":"CC Zouboulis","year":"1997","unstructured":"Zouboulis CC, K\u00f6tter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Beh\u00e7et\u2019s disease in Germany and in Europe. Yonsei Med J. 1997;38:411\u201322.","journal-title":"Yonsei Med J"},{"key":"843_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","volume":"12","author":"Y Yazici","year":"2010","unstructured":"Yazici Y, Yurdakul S, Yazici H. Beh\u00e7et\u2019s syndrome. Curr Rheumatol Rep. 2010;12:429\u201335.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"843_CR9","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1002\/art.24149","volume":"58","author":"A Mahr","year":"2008","unstructured":"Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Beh\u00e7et\u2019s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58(12):3951\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"843_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/BOR.0000000000000349","volume":"29","author":"P Leccese","year":"2017","unstructured":"\u2022 Leccese P, Yazici Y, Olivieri I. Behcet\u2019s syndrome in nonendemic regions. Curr Opin Rheumatol. 2017;29(1):12\u20136. This paper points out the increased prevalence of BS in non-endemic regions due to immigration from endemic countries.","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 12","key":"843_CR11","first-page":"34","volume":"23","author":"H Ozdo\u011fan","year":"1994","unstructured":"Ozdo\u011fan H. Beh\u00e7et\u2019s syndrome in children. Rheumatol Eur. 1994;23(Suppl 12):34.","journal-title":"Rheumatol Eur"},{"issue":"5","key":"843_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"S Yurdakul","year":"2008","unstructured":"Yurdakul S, Yazici H. Behcet\u2019s syndrome. Best Pract Res Clin Rheumatol. 2008;22(5):793\u2013809.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"843_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82:60\u201376.","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"843_CR14","doi-asserted-by":"publisher","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","volume":"95","author":"I Hatemi","year":"2016","unstructured":"Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet\u2019s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95(16):e3348.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"843_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H. Autoimmunity vs autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006;45(12):1461\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"843_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"A Gul","year":"2005","unstructured":"Gul A. Behcet\u2019s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy. 2005;4:81\u20133.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"843_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaut.2017.08.002","volume":"84","author":"S Lule","year":"2017","unstructured":"\u2022 Lule S, Colpak AI, Balci-Peynircioglu B, Gursoy-Ozdemir Y, Peker S, Kalyoncu U, et al. Beh\u00e7et disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J Autoimmun. 2017;84:87\u201396. The authors found a new antigen showing cross reactivity with the bacterial protein HSP-65 supporting the autoimmune disease theory in BS.","journal-title":"J Autoimmun"},{"issue":"5","key":"843_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford). 2012;51(5):887\u2013900.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"843_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","volume":"11","author":"D McGonagle","year":"2015","unstructured":"McGonagle D, Aydin SZ, G\u00fcl A, Mahr A, Direskeneli H. \u201cMHC-I-opathy\u201d\u2014unified concept for spondyloarthritis and Beh\u00e7et disease. Nat Rev Rheumatol. 2015;11(12):731\u201340.","journal-title":"Nat Rev Rheumatol"},{"issue":"6 Suppl 102","key":"843_CR20","first-page":"23","volume":"34","author":"H Yazici","year":"2016","unstructured":"Yazici H. Beh\u00e7et\u2019s syndrome in the 2000s: \u201cwhere is the wisdom we have lost in knowledge?\u201d. Clin Exp Rheumatol. 2016;34(6 Suppl 102):23\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"843_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Behcet IG. \u2019s disease. N Engl J Med. 1999;341:1284\u201391.","journal-title":"N Engl J Med"},{"key":"843_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4419-5641-5_13","volume-title":"Beh\u00e7et\u2019s syndrome","author":"C Demirkesen","year":"2010","unstructured":"Demirkesen C, \u00d6z B, G\u00f6ksel S. Beh\u00e7et\u2019s disease: pathology. In: Yaz\u0131c\u0131 Y, Yaz\u0131c\u0131 H, editors. Beh\u00e7et\u2019s syndrome. Berlin: Springer; 2010. p. 215\u201341."},{"issue":"2","key":"843_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.rdc.2013.02.010","volume":"39","author":"G Hatemi","year":"2013","unstructured":"Hatemi G, Yazici Y, Yazici H. Beh\u00e7et\u2019s syndrome. Rheum Dis Clin N Am. 2013;39(2):245\u201361.","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"843_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3349\/ymj.1997.38.6.370","volume":"38","author":"RS Rogers 3rd","year":"1997","unstructured":"Rogers RS 3rd. Recurrent aphthous stomatitis in the diagnosis of Behcet\u2019s disease. Yonsei Med J. 1997;38(6):370\u20139.","journal-title":"Yonsei Med J"},{"key":"843_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/JMDH.S93681","volume":"10","author":"SN Esatoglu","year":"2017","unstructured":"Esatoglu SN, Kutlubay Z, Ucar D, Hatemi I, Uygunoglu U, Siva A, et al. Beh\u00e7et\u2019s syndrome: providing integrated care. J Multidiscip Healthc. 2017;10:309\u201319.","journal-title":"J Multidiscip Healthc"},{"issue":"5","key":"843_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1365-4632.2006.02859.x","volume":"45","author":"MC Mat","year":"2006","unstructured":"Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H. The frequency of scarring after genital ulcers in Behcet\u2019s syndrome: a prospective study. Int J Dermatol. 2006;45(5):554\u20136.","journal-title":"Int J Dermatol"},{"key":"843_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/rheumatology\/31.5.299","volume":"31","author":"The International Study Group for Beh\u00e7et\u2019s Disease","year":"1992","unstructured":"The International Study Group for Beh\u00e7et\u2019s Disease. Evaluation of diagnostic (\u2018classification\u2019) criteria in Beh\u00e7et\u2019s disease\u2014towards internationally agreed criteria. Br J Rheumatol. 1992;31:299\u2013308.","journal-title":"Br J Rheumatol"},{"issue":"12","key":"843_CR28","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s00415-013-7070-4","volume":"260","author":"DP Kidd","year":"2013","unstructured":"Kidd DP. Optic neuropathy in Beh\u00e7et\u2019s syndrome. J Neurol. 2013;260(12):3065\u201370.","journal-title":"J Neurol"},{"issue":"12","key":"843_CR29","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","volume":"91","author":"N Kitaichi","year":"2007","unstructured":"Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behcet\u2019s disease: an international collaborative study. Br J Ophthalmol. 2007;91(12):1579\u201382.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"843_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/09273948.2012.713159","volume":"20","author":"AK Cingu","year":"2012","unstructured":"Cingu AK, Onal S, Urgancioglu M, Tugal-Tutkun I. Comparison of presenting features and three-year disease course in Turkish patients with Beh\u00e7et uveitis who presented in the early 1990s and the early 2000s. Ocul Immunol Inflamm. 2012;20(6):423\u20138.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"843_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09273948.2016.1205100","volume":"25","author":"I Tugal-Tutkun","year":"2017","unstructured":"Tugal-Tutkun I, Ozdal PC, Oray M, Onal S. Review for diagnostics of the year: multimodal imaging in Beh\u00e7et uveitis. Ocul Immunol Inflamm. 2017;25(1):7\u201319.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"843_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.rdc.2017.09.007","volume":"44","author":"I Hatemi","year":"2018","unstructured":"Hatemi I, Hatemi G, \u00c7elik AF. Gastrointestinal involvement in Beh\u00e7et disease. Rheum Dis Clin N Am. 2018;44(1):45\u201364.","journal-title":"Rheum Dis Clin N Am"},{"key":"843_CR33","doi-asserted-by":"publisher","first-page":"653806","DOI":"10.1155\/2012\/653806","volume":"2012","author":"A Bicer","year":"2012","unstructured":"Bicer A. Musculoskeletal findings in Behcet\u2019s disease. Pathol Res Int. 2012;2012:653806.","journal-title":"Pathol Res Int"},{"issue":"11","key":"843_CR34","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","volume":"53","author":"K Tascilar","year":"2014","unstructured":"Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Beh\u00e7et\u2019s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014;53(11):2018\u201322.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"843_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1540-8191.2008.00607.x","volume":"23","author":"M Marzban","year":"2008","unstructured":"Marzban M, Mandegar MH, Karimi A, Abbasi K, Movahedi N, Navabi MA, et al. Cardiac and great vessel involvement in \u201cBehcet\u2019s disease\u201d. J Card Surg. 2008;23(6):765\u20138.","journal-title":"J Card Surg"},{"issue":"1","key":"843_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, et al. Pulmonary artery involvement and associated lung disease in Behcet disease: a series of 47 patients. Medicine (Baltimore). 2012;91(1):35\u201348.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"843_CR37","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","volume":"261","author":"S Kalra","year":"2014","unstructured":"\u2022\u2022 Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, et al. Diagnosis and management of neuro-Beh\u00e7et\u2019s disease: international consensus recommendations. J Neurol. 2014;261(9):1662\u201376. This study reports international consensus recommendations for NBS diagnosis.","journal-title":"J Neurol"},{"issue":"2","key":"843_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Beh\u00e7et\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 2001;248(2):95\u2013103.","journal-title":"J Neurol"},{"issue":"4","key":"843_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","volume":"256","author":"A Siva","year":"2009","unstructured":"Siva A, Saip S. The spectrum of nervous system involvement in Beh\u00e7et\u2019s syndrome and its differential diagnosis. J Neurol. 2009;256(4):513\u201329.","journal-title":"J Neurol"},{"issue":"1","key":"843_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ncl.2017.08.014","volume":"36","author":"A Siva","year":"2018","unstructured":"Siva A. Common clinical and imaging conditions misdiagnosed as multiple sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. Neurol Clin. 2018;36(1):69\u2013117.","journal-title":"Neurol Clin"},{"issue":"21","key":"843_CR41","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1212\/WNL.0b013e318238edeb","volume":"77","author":"D Uluduz","year":"2011","unstructured":"Uluduz D, K\u00fcrt\u00fcnc\u00fc M, Yap\u0131c\u0131 Z, Seyahi E, Kasap\u00e7opur \u00d6, \u00d6zdo\u011fan H, et al. Clinical characteristics of pediatric-onset neuro-Behcet disease. Neurology. 2011;77(21):1900\u20135.","journal-title":"Neurology"},{"key":"843_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1526-4610.2005.05160.x","volume":"45","author":"S Saip","year":"2005","unstructured":"Saip S, Siva A, Altintas A, Kiyat A, Seyahi E, Hamuryudan V, et al. Headache in Behcet\u2019s syndrome. Headache. 2005;45:911\u20139.","journal-title":"Headache"},{"key":"843_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10194-015-0589-2","volume":"16","author":"B Baykan","year":"2015","unstructured":"Baykan B, Ertas M, Karl\u0131 N, Uluduz D, Uygunoglu U, Ekizoglu E, et al. Migraine incidence in 5\u00a0years: a population-based prospective longitudinal study in Turkey. J Headache Pain. 2015;16:103.","journal-title":"J Headache Pain"},{"key":"843_CR44","first-page":"247","volume-title":"Recent advances in Beh\u00e7et\u2019s disease","author":"A Siva","year":"1986","unstructured":"Siva A, \u00d6zdo\u011fan H, Yaz\u0131c\u0131 H, Yurdakul S, Yard\u0131m M, Akyatan N, et al. Headache, neuro-psychiatric and computerized tomography findings in Beh\u00e7et\u2019s syndrome. In: Lehner T, Barnes CG, editors. Recent advances in Beh\u00e7et\u2019s disease. London: Royal Society of Medicine Service; 1986. p. 247\u201354."},{"issue":"4 Suppl 84","key":"843_CR45","first-page":"S175","volume":"32","author":"Y Keskin","year":"2014","unstructured":"Keskin Y, Seyahi E, Poyraz C, Ugurlu S, Ozyazgan Y, Yazici H. Interferon alfa-associated depression in patients with Beh\u00e7et\u2019s syndrome: a prospective controlled study. Clin Exp Rheumatol. 2014;32(4 Suppl 84):S175.","journal-title":"Clin Exp Rheumatol"},{"issue":"3\u20134","key":"843_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000355277","volume":"71","author":"U Uyguno\u011flu","year":"2014","unstructured":"Uyguno\u011flu U, Benbir G, Saip S, Kaynak H, Siva A. A polysomnographic and clinical study of sleep disorders in patients with Beh\u00e7et and neuro-Beh\u00e7et syndrome. Eur Neurol. 2014;71(3\u20134):115\u20139.","journal-title":"Eur Neurol"},{"issue":"11","key":"843_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3109\/00207454.2012.704454","volume":"122","author":"T G\u00fcnd\u00fcz","year":"2012","unstructured":"G\u00fcnd\u00fcz T, Emir \u00d6, K\u00fcrt\u00fcnc\u00fc M, Mutlu M, Tuma\u00e7 A, Akca S, et al. Cognitive impairment in neuro-Behcet\u2019s disease and multiple sclerosis: a comparative study. Int J Neurosci. 2012;122(11):650\u20136.","journal-title":"Int J Neurosci"},{"key":"843_CR48","unstructured":"Uygunoglu U, Saip S, Siva A. Behcet\u2019s syndrome and nervous system involvement. In: Lisak RP, Truong DD, Carroll WM, et al., editors. International neurology, vol. 2016. 2nd ed. Chichester: John Wiley & Sons, Ltd. p. 88\u201393. Chapter 28."},{"key":"843_CR49","doi-asserted-by":"publisher","first-page":"261502","DOI":"10.1100\/2012\/261502","volume":"2012","author":"A Alkan","year":"2012","unstructured":"Alkan A, Goktan A, Karincaoglu Y, Kamisli S, Dogan M, Oztanir N, et al. Brain perfusion MRI findings in patients with Behcet\u2019s disease. Sci World J. 2012;2012:261502.","journal-title":"Sci World J"},{"issue":"4","key":"843_CR50","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neurad.2013.01.001","volume":"40","author":"YW Chuang","year":"2013","unstructured":"Chuang YW, Hsu CC, Huang YF, Lin HF, Chang CC, Lin CY, et al. Brain perfusion SPECT in patients with Beh\u00e7et\u2019s disease. J Neuroradiol. 2013;40(4):288\u201393.","journal-title":"J Neuroradiol"},{"key":"843_CR51","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/B978-0-7020-4088-7.00110-3","volume":"121","author":"S Saip","year":"2014","unstructured":"Saip S, Akman-Demir G, Siva A. Neuro-Beh\u00e7et syndrome. Handb Clin Neurol. 2014;121:1703\u201323.","journal-title":"Handb Clin Neurol"},{"issue":"Pt 11","key":"843_CR52","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tas\u00e7i B. Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. The neuro-Beh\u00e7et study group. Brain. 1999;122(Pt 11):2171\u201382.","journal-title":"Brain"},{"issue":"1","key":"843_CR53","doi-asserted-by":"publisher","first-page":"10196","DOI":"10.1038\/s41598-017-09938-z","volume":"7","author":"M Ishido","year":"2017","unstructured":"Ishido M, Horita N, Takeuchi M, Shibuya E, Yamane T, Kawagoe T, et al. Distinct clinical features between acute and chronic progressive parenchymal neuro-Beh\u00e7et disease: meta-analysis. Sci Rep. 2017;7(1):10196.","journal-title":"Sci Rep"},{"key":"843_CR54","first-page":"1015","volume":"20","author":"N Kocer","year":"1999","unstructured":"Kocer N, Islak C, Siva A, et al. CNS involvement in neuro-Behcet\u2019s syndrome: an MR study. AJNR Am J Neuroradiol. 1999;20:1015\u201324.","journal-title":"AJNR Am J Neuroradiol"},{"key":"843_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clineuro.2017.08.004","volume":"161","author":"F Cohen-Aubart","year":"2017","unstructured":"Cohen-Aubart F, Psimaras D, Galanaud D, Bielle F, Touitou V, Haroche J, et al. Cerebral pseudo-tumoral neuro-Behcet: histological demonstration of an inflammatory and vascular disease. Clin Neurol Neurosurg. 2017;161:48\u201350.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"843_CR56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13256-016-1151-9","volume":"10","author":"M Yeo","year":"2016","unstructured":"Yeo M, Lee HL, Cha M, Kim JS, Han HS, Lee SH, et al. Neuro-Behcet disease presenting as a solitary cerebellar hemorrhagic lesion: a case report and review of the literature. J Med Case Rep. 2016;10(1):360.","journal-title":"J Med Case Rep"},{"issue":"1\u20132","key":"843_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jns.2008.10.003","volume":"277","author":"O Taskapilioglu","year":"2009","unstructured":"Taskapilioglu O, Seferoglu M, Akkaya C, Hakyemez B, Yusufoglu C, Basak AN, et al. Delayed diagnosis of a neuro-Beh\u00e7et patient with only brainstem and cerebellar atrophy: literature review. J Neurol Sci. 2009;277(1\u20132):160\u20133.","journal-title":"J Neurol Sci"},{"issue":"6","key":"843_CR58","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3174\/ajnr.A2477","volume":"32","author":"S Albayram","year":"2011","unstructured":"Albayram S, Saip S, Hasiloglu ZI, Teke M, Ceyhan E, Tutuncu M, et al. Evaluation of parenchymal neuro-Beh\u00e7et disease by using susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2011;32(6):1050\u20135.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"843_CR59","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jocn.2008.05.018","volume":"16","author":"D Ilhan","year":"2009","unstructured":"Ilhan D, Gulcan E, Uzuner N, Celikkas E. Cerebrovascular manifestations of Beh\u00e7et\u2019s disease. J Clin Neurosci. 2009;16(4):576\u20138.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"843_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s002340050742","volume":"41","author":"O Coban","year":"1999","unstructured":"Coban O, Bahar S, Akman-Demir G, Ta\u015fci B, Yurdakul S, Yazici H, et al. Masked assessment of MRI findings: is it possible to differentiate neuro-Beh\u00e7et\u2019s disease from other central nervous system diseases? Neuroradiology. 1999;41(4):255\u201360.","journal-title":"Neuroradiology"},{"issue":"1\u20132","key":"843_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata S. Histopathology of central nervous system lesions in Beh\u00e7et\u2019s disease. J Neurol Sci. 2008;267(1\u20132):41\u20137.","journal-title":"J Neurol Sci"},{"issue":"2","key":"843_CR62","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.25004","volume":"82","author":"U Uygunoglu","year":"2017","unstructured":"\u2022\u2022 Uygunoglu U, Zeydan B, Ozguler Y, et al. Myelopathy in Beh\u00e7et\u2019s disease: the Bagel sign. Ann Neurol. 2017;82(2):288\u201398. The authors described a new pattern in BS patients presenting with spinal card involvement. This pattern labeled as \u2018Bagel sign\u2019. Together with other findings, \u2018Bagel sign\u2019 supports the venous theory in BS pathogenesis.","journal-title":"Ann Neurol"},{"key":"843_CR63","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1177\/1352458515613642","volume":"22","author":"HS Lee","year":"2016","unstructured":"Lee HS, Kim do Y, Shin HY, Choi YC, Kim SM. Spinal cord involvement in Behcet\u2019s disease. Mult Scler. 2016;22:960\u20133.","journal-title":"Mult Scler"},{"key":"843_CR64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1179\/2045772311Y.0000000050","volume":"35","author":"I Coulter","year":"2012","unstructured":"Coulter I, Huda S, Baborie A, Jacob A. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behcet\u2019s disease responding to infliximab. J Spinal Cord Med. 2012;35:122\u20134.","journal-title":"J Spinal Cord Med"},{"key":"843_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1179\/2045772314Y.0000000209","volume":"38","author":"U Uygunoglu","year":"2015","unstructured":"Uygunoglu U, Pasha M, Saip S, Siva A. Recurrent longitudinal extensive transverse myelitis in a neuro-Behcet syndrome treated with infliximab. J Spinal Cord Med. 2015;38:111\u20134.","journal-title":"J Spinal Cord Med"},{"key":"843_CR66","doi-asserted-by":"publisher","unstructured":"Maggi P, Absinta M, Grammatico M, et al. The central vein sign differentiates MS from CNS inflammatory vasculopathies. Ann Neurol. 2018; https:\/\/doi.org\/10.1002\/ana.25146 .","DOI":"10.1002\/ana.25146"},{"issue":"3 Suppl 77","key":"843_CR67","first-page":"25","volume":"31","author":"G Saruhan-Direskeneli","year":"2013","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Mutlu M, Shugaiv E, Yesilot N, K\u00fcrt\u00fcnc\u00fc M, et al. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Beh\u00e7et\u2019s disease. Clin Exp Rheumatol. 2013;31(3 Suppl 77):25\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"843_CR68","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","volume":"256","author":"N Yesilot","year":"2009","unstructured":"Yesilot N, Bahar S, Yilmazer S, Mutlu M, Kurtuncu M, Tuncay R, et al. Cerebral venous thrombosis in Beh\u00e7et\u2019s disease compared to those associated with other etiologies. J Neurol. 2009;256(7):1134\u201342.","journal-title":"J Neurol"},{"key":"843_CR69","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications of Behcet\u2019s syndrome. Brain. 1999;122:2183\u201394.","journal-title":"Brain"},{"issue":"3","key":"843_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","volume":"22","author":"S Hirohata","year":"2012","unstructured":"Hirohata S, Kikuchi H, Sawada T, Nagafuchi H, Kuwana M, Takeno M, et al. Clinical characteristics of neuro-Behcet\u2019s disease in Japan: a multicenter retrospective analysis. Mod Rheumatol. 2012;22(3):405\u201313.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"843_CR71","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11940-011-0120-2","volume":"13","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Saip S, Siva A. Beh\u00e7et\u2019s disease. Curr Treat Options Neurol. 2011;13(3):290\u2013310.","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"843_CR72","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1212\/NXI.0000000000000258","volume":"3","author":"B Zeydan","year":"2016","unstructured":"\u2022\u2022 Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, et al. Infliximab is a plausible alternative for neurologic complications of Beh\u00e7et disease. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e258. The authors observed that patients receiving infliximab did not have any further relapses during treatment. Additionally, none of the patients had neurological involvement while they were receiving infliximab for BS symptoms.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"843_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000434684","volume":"90","author":"S Borekci","year":"2015","unstructured":"Borekci S, Atahan E, Demir Yilmaz D, Maz\u0131can N, Duman B, Ozguler Y, et al. Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-\u03b1 treatment. Respiration. 2015;90(3):191\u20138.","journal-title":"Respiration"},{"key":"843_CR74","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","unstructured":"British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-\u03b1 treatment. Thorax. 2005;60:800\u20135.","journal-title":"Thorax"},{"issue":"12","key":"843_CR75","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/art.40235","volume":"69","author":"PP Sfikakis","year":"2017","unstructured":"Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, et al. Brief report: drug-free long-term remission in severe Beh\u00e7et\u2019s disease following withdrawal of successful anti-tumor necrosis factor treatment. Arthritis Rheumatol. 2017;69(12):2380\u20135.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"843_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1517\/14740338.2016.1112375","volume":"15","author":"G Murdaca","year":"2016","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Penza E, Magnani O, et al. Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? Expert Opin Drug Saf. 2016;15(1):43\u201352.","journal-title":"Expert Opin Drug Saf"},{"key":"843_CR77","doi-asserted-by":"publisher","unstructured":"Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome. Ann Rheum Dis. 2018. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225 .","DOI":"10.1136\/annrheumdis-2018-213225"},{"key":"843_CR78","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","volume":"25","author":"I K\u00f6tter","year":"2006","unstructured":"K\u00f6tter I, G\u00fcnaydin I, Batra M, Vonthein R, St\u00fcbiger N, Fierlbeck G, et al. CNS involvement occurs more frequently in patients with Behcet\u2019s disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin Rheumatol. 2006;25:482\u20136.","journal-title":"Clin Rheumatol"},{"key":"843_CR79","first-page":"S84","volume":"26","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I. Cyclosporine for Behcet\u2019s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol. 2008;26:S84\u201390.","journal-title":"Clin Exp Rheumatol"},{"key":"843_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MD.0b013e318211bf28","volume":"90","author":"H Ideguchi","year":"2011","unstructured":"Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behcet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90:125\u201332.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"843_CR81","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP. Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8(2):192\u2013204.","journal-title":"Lancet Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0843-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:57:48Z","timestamp":1661302668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0843-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0843-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"23 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"U\u011fur Uyguno\u011flu declares no potential conflicts of interest.Aksel Siva declares no potential conflicts of interest related to this article. His otherwise disclosures are honoraria and consultation fees from Novartis, Genzyme, Bayer, Biogen Idec, Merck Serono; Genzyme, Teva, and Roche; received travel and registration coverage for attending several national or international congresses or symposia, from Merck Serono, Biogen Idec\/Gen Pharma of Turkey, Novartis, Teva; Genzyme and Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"35"}}